UNASSIGNED:作为一项新兴的微创技术,据报道,在某些情况下,内镜超声(EUS)可替代手术或图像引导经皮穿刺引流术(PCD)治疗盆腔脓肿.这项研究的目的是评估EUS引导下引流对盆腔脓肿患者的疗效和安全性。
UNASSIGNED:我们对PubMed进行了全面的文献检索,Embase,科克伦图书馆,和WebofScience数据库(开始-2022年3月)。主要成果是技术上的成功,临床成功,和并发症。使用综合荟萃分析软件计算合并事件率。
UNASSIGNED:纳入了12项包含272名患者的研究。这些盆腔脓肿在腹部和盆腔手术后最常见(n=180,66.2%),炎症性肠病(n=32,11.8%),和其他炎症。分别,合并的技术和临床成功率为100%和88.7%[95%置信区间(CI):83.8-92.2%,I2=1.0%,p<0.001]。排除个别研究后,并发症的合并率从11.5%(95%CI:7.4-17.4%,I2=38.8%,p<0.001)至8.2%(95%CI:5.0-13.3%,I2=0,p<0.001)。
UNASSIGNED:EUS引导盆腔脓肿引流是可行的,有效,和安全。未来需要进一步的大样本量随机对照研究。
UNASSIGNED: As an emerging minimally invasive technology, endoscopic ultrasound (EUS) has been reported to treat pelvic abscess instead of surgical or image-guided percutaneous drainage (PCD) under certain conditions. The aim of this study was to assess the efficacy and safety of EUS-guided drainage for patients with pelvic abscesses.
UNASSIGNED: We conducted a comprehensive literature search on PubMed, Embase, Cochrane Library, and Web of Science databases (inception-March 2022). The main outcomes were technical success, clinical success, and complications. Comprehensive meta-analysis software was used to calculate the pooled event rate.
UNASSIGNED: Twelve studies containing 272 patients were included. These pelvic abscesses most frequently developed after abdominal and pelvic surgery (n = 180, 66.2%), inflammatory bowel disease (n = 32, 11.8%), and other inflammatory conditions. Respectively, the pooled technical and clinical success rate was 100% and 88.7% [95% confidence interval (CI): 83.8-92.2%, I2 = 1.0%, p < 0.001]. After excluding an individual study, the pooled rate of complications changed from 11.5% (95% CI: 7.4-17.4%, I2 = 38.8%, p < 0.001) to 8.2% (95% CI: 5.0-13.3%, I2 = 0, p < 0.001).
UNASSIGNED: EUS-guided drainage of the pelvic abscess was feasible, effective, and safe. Further randomized-controlled studies with large-sample sizes were required in the future.